Designing Next-Generation Drug-Like Molecules for Medicinal Applications
The development of new drugs/drug candidates for medical treatment remains an exciting but challenging process as only a limited number of synthetic compounds fit well into the discovery and development process after multiple experimentation and screening efforts in search of their preclinical prope...
में बचाया:
| स्वरूप: | Online |
|---|---|
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
MDPI - Multidisciplinary Digital Publishing Institute
2025
|
| विषय: | |
| ऑनलाइन पहुंच: | ONIX_20250220_9783725830084_520 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|
| _version_ | 1869515886373634048 |
|---|---|
| collection | Directory of Open Access Books |
| description | The development of new drugs/drug candidates for medical treatment remains an exciting but challenging process as only a limited number of synthetic compounds fit well into the discovery and development process after multiple experimentation and screening efforts in search of their preclinical properties. Over the years, this continuous demand has been fueled by the use of organic/synthetic chemistry protocols that deliver new molecules or improve the existing toolbox diversifying libraries of pharmacophores of medicinal interest. The application of new methodologies particularly employing green and sustainable commercial feedstock chemicals for the discovery and development of biological therapeutics opens up new avenues of research. In parallel, the discovery and development of new organic molecules have always proved effective in designing drugs while overcoming critical challenges to the pharmaceutical industry and providing innovative solutions toward commercialized medicines. This reprint aims to provide a far-reaching overview of the most recent developments in synthetic methodologies as well as medicinal chemistry applications of small-molecule inhibitors. |
| format | Online |
| id | doab-20.500.12854ir-153156 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1531562025-02-20T13:38:59Z Designing Next-Generation Drug-Like Molecules for Medicinal Applications Khan, Imtiaz Zaib, Sumera anthraquinones antidiabetic antimicrobial Cassia obtusifolia L. hepatoprotection neuro protection spirooxindole azomethine ylides [3+2] cycloaddition reaction anti-cancer activity amide anti-inflammatory COX-2 iNOS NO PGE2 pyrazole quinoline thiosemicarbazone molecular design hybridization Alzheimer’s disease neurodegeneration drug therapy cholinesterases enzyme inhibition molecular docking diabetes drug delivery α-glucosidase in vivo studies α-mangostin nanosponges quasi-emulsion method HER4 ErbB4 cancer kinase inhibitors structure-activity relationship hesperetin derivatives PTP1B hesperetin 5-O-glucoside baricitinib bioavailability encapsulation hybrid nanoparticles poly(d,l-lactide-coglycolide) stearin anticancer kinase inhibitor neurodegenerative disorders deep machine learning generative modeling kinase inhibitor design Bruton’s tyrosine kinase covalent inhibitors 3-phenyl-β-alanine 1,3,4-oxadiazole hybrids carbonic anhydrase-II dental caries biofilm glucosyltransferases virtual screening antibiofilm antimicrobial ADMET profiling triterpenoic acid ursolic acid oleanolic acid betulinic acid rhodamine B rhodamine 101 cytotoxicity SARS-CoV-2 nsp16-nsp10 2′-o-methyltransferase FDA approved drugs molecular fingerprints structural similarity MD simulations MMPBSA immunomodulatory apoptosis in silico studies nicotinamide VEGFR-2 amino acyl coumarins (pseudo)-dipeptidyl coumarins carbonic anhydrases (CAs) monoamine oxidases (MAOs) iodinated histidines membrane active peptides anticryptococcal activity iodopeptides pore formation cell lysis antifungal agents n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PH Physics::PHH Thermodynamics and heat The development of new drugs/drug candidates for medical treatment remains an exciting but challenging process as only a limited number of synthetic compounds fit well into the discovery and development process after multiple experimentation and screening efforts in search of their preclinical properties. Over the years, this continuous demand has been fueled by the use of organic/synthetic chemistry protocols that deliver new molecules or improve the existing toolbox diversifying libraries of pharmacophores of medicinal interest. The application of new methodologies particularly employing green and sustainable commercial feedstock chemicals for the discovery and development of biological therapeutics opens up new avenues of research. In parallel, the discovery and development of new organic molecules have always proved effective in designing drugs while overcoming critical challenges to the pharmaceutical industry and providing innovative solutions toward commercialized medicines. This reprint aims to provide a far-reaching overview of the most recent developments in synthetic methodologies as well as medicinal chemistry applications of small-molecule inhibitors. 2025-02-20T13:38:57Z 2025-02-20T13:38:57Z 2025 book ONIX_20250220_9783725830084_520 9783725830084 9783725830077 https://directory.doabooks.org/handle/20.500.12854/153156 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/10429 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-3007-7 10.3390/books978-3-7258-3007-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725830084 9783725830077 398 Basel open access |
| spellingShingle | anthraquinones antidiabetic antimicrobial Cassia obtusifolia L. hepatoprotection neuro protection spirooxindole azomethine ylides [3+2] cycloaddition reaction anti-cancer activity amide anti-inflammatory COX-2 iNOS NO PGE2 pyrazole quinoline thiosemicarbazone molecular design hybridization Alzheimer’s disease neurodegeneration drug therapy cholinesterases enzyme inhibition molecular docking diabetes drug delivery α-glucosidase in vivo studies α-mangostin nanosponges quasi-emulsion method HER4 ErbB4 cancer kinase inhibitors structure-activity relationship hesperetin derivatives PTP1B hesperetin 5-O-glucoside baricitinib bioavailability encapsulation hybrid nanoparticles poly(d,l-lactide-coglycolide) stearin anticancer kinase inhibitor neurodegenerative disorders deep machine learning generative modeling kinase inhibitor design Bruton’s tyrosine kinase covalent inhibitors 3-phenyl-β-alanine 1,3,4-oxadiazole hybrids carbonic anhydrase-II dental caries biofilm glucosyltransferases virtual screening antibiofilm antimicrobial ADMET profiling triterpenoic acid ursolic acid oleanolic acid betulinic acid rhodamine B rhodamine 101 cytotoxicity SARS-CoV-2 nsp16-nsp10 2′-o-methyltransferase FDA approved drugs molecular fingerprints structural similarity MD simulations MMPBSA immunomodulatory apoptosis in silico studies nicotinamide VEGFR-2 amino acyl coumarins (pseudo)-dipeptidyl coumarins carbonic anhydrases (CAs) monoamine oxidases (MAOs) iodinated histidines membrane active peptides anticryptococcal activity iodopeptides pore formation cell lysis antifungal agents n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PH Physics::PHH Thermodynamics and heat Designing Next-Generation Drug-Like Molecules for Medicinal Applications |
| title | Designing Next-Generation Drug-Like Molecules for Medicinal Applications |
| title_full | Designing Next-Generation Drug-Like Molecules for Medicinal Applications |
| title_fullStr | Designing Next-Generation Drug-Like Molecules for Medicinal Applications |
| title_full_unstemmed | Designing Next-Generation Drug-Like Molecules for Medicinal Applications |
| title_short | Designing Next-Generation Drug-Like Molecules for Medicinal Applications |
| title_sort | designing next generation drug like molecules for medicinal applications |
| topic | anthraquinones antidiabetic antimicrobial Cassia obtusifolia L. hepatoprotection neuro protection spirooxindole azomethine ylides [3+2] cycloaddition reaction anti-cancer activity amide anti-inflammatory COX-2 iNOS NO PGE2 pyrazole quinoline thiosemicarbazone molecular design hybridization Alzheimer’s disease neurodegeneration drug therapy cholinesterases enzyme inhibition molecular docking diabetes drug delivery α-glucosidase in vivo studies α-mangostin nanosponges quasi-emulsion method HER4 ErbB4 cancer kinase inhibitors structure-activity relationship hesperetin derivatives PTP1B hesperetin 5-O-glucoside baricitinib bioavailability encapsulation hybrid nanoparticles poly(d,l-lactide-coglycolide) stearin anticancer kinase inhibitor neurodegenerative disorders deep machine learning generative modeling kinase inhibitor design Bruton’s tyrosine kinase covalent inhibitors 3-phenyl-β-alanine 1,3,4-oxadiazole hybrids carbonic anhydrase-II dental caries biofilm glucosyltransferases virtual screening antibiofilm antimicrobial ADMET profiling triterpenoic acid ursolic acid oleanolic acid betulinic acid rhodamine B rhodamine 101 cytotoxicity SARS-CoV-2 nsp16-nsp10 2′-o-methyltransferase FDA approved drugs molecular fingerprints structural similarity MD simulations MMPBSA immunomodulatory apoptosis in silico studies nicotinamide VEGFR-2 amino acyl coumarins (pseudo)-dipeptidyl coumarins carbonic anhydrases (CAs) monoamine oxidases (MAOs) iodinated histidines membrane active peptides anticryptococcal activity iodopeptides pore formation cell lysis antifungal agents n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PH Physics::PHH Thermodynamics and heat |
| topic_facet | anthraquinones antidiabetic antimicrobial Cassia obtusifolia L. hepatoprotection neuro protection spirooxindole azomethine ylides [3+2] cycloaddition reaction anti-cancer activity amide anti-inflammatory COX-2 iNOS NO PGE2 pyrazole quinoline thiosemicarbazone molecular design hybridization Alzheimer’s disease neurodegeneration drug therapy cholinesterases enzyme inhibition molecular docking diabetes drug delivery α-glucosidase in vivo studies α-mangostin nanosponges quasi-emulsion method HER4 ErbB4 cancer kinase inhibitors structure-activity relationship hesperetin derivatives PTP1B hesperetin 5-O-glucoside baricitinib bioavailability encapsulation hybrid nanoparticles poly(d,l-lactide-coglycolide) stearin anticancer kinase inhibitor neurodegenerative disorders deep machine learning generative modeling kinase inhibitor design Bruton’s tyrosine kinase covalent inhibitors 3-phenyl-β-alanine 1,3,4-oxadiazole hybrids carbonic anhydrase-II dental caries biofilm glucosyltransferases virtual screening antibiofilm antimicrobial ADMET profiling triterpenoic acid ursolic acid oleanolic acid betulinic acid rhodamine B rhodamine 101 cytotoxicity SARS-CoV-2 nsp16-nsp10 2′-o-methyltransferase FDA approved drugs molecular fingerprints structural similarity MD simulations MMPBSA immunomodulatory apoptosis in silico studies nicotinamide VEGFR-2 amino acyl coumarins (pseudo)-dipeptidyl coumarins carbonic anhydrases (CAs) monoamine oxidases (MAOs) iodinated histidines membrane active peptides anticryptococcal activity iodopeptides pore formation cell lysis antifungal agents n/a thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general thema EDItEUR::P Mathematics and Science::PH Physics::PHH Thermodynamics and heat |
| url | ONIX_20250220_9783725830084_520 |